Big moves are continuing in the weight loss landscape in the new year following breakthrough research of GLP-1 medications and other methods. Weight-loss experts spoke with Fox News Digital about ...
Fractyl Health, Inc. ( (GUTS)) has shared an update. On January 5, 2026, Fractyl Health outlined a catalyst-heavy 2026 plan centered on progressing Revita through pivotal validation in post-GLP-1 ...
Weight-loss injectables for pets? Okava Pharmaceuticals announced plans to kick off a pilot study of a GLP-1 drug for cats with obesity. (New York Times) Novo Nordisk submitted a higher-dose version ...
Diabetes mellitus is a multifactorial metabolic disorder characterized by chronic hyperglycemia and progressive multisystem complications. Growing evidences positions the microbiome (including ...
The project is expected to result in more than 1,200 new job opportunities. The Acadiana site will serve as DMR’s primary domestic production hub. Operations at the renovated facility are expected to ...
Fractyl Health specializes in disease-modifying therapies for obesity and T2D. Its aim is to address underlying causes of these conditions rather than just manage symptoms. The company's approach ...
DMR/Interactive and PromoSuite are extending their two-decade partnership, adding increased automation and continued support for station-level database activation and email marketing aimed at radio ...
Bariatric surgery, particularly RYGB and VSG, significantly improves liver health in MASLD, with high rates of steatosis remission and fibrosis reduction. Endoscopic techniques, such as ESG, IGBs, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results